The activist investor Mayers Ventures now holds a meaningful stake via the acquisition shares, and the cashless warrant exercise by Mandragola adds further overhang. Monitor for any additional 13D filings or public statements from Mayers regarding strategic direction, and watch for further ATM sales given management's statement that they may halt the program 'when management deems it appropriate.'
Price Chart
Executive Summary
Tessera issued 3,473,039 restricted shares (3,278,039 to Mandragola on cashless warrant exercise, 195,000 to Mayers Ventures for an equity interest in MEA Testing Systems and an option to acquire MEA's remaining interest). The company also disclosed raising over $6M net through its ATM program at ~$1.11/share post-reverse-split. The activist investor Mayers Ventures (filer of the SC 13D/A filed 7 days ago) received shares as part of a strategic investment, linking the dilution to an acquisition rather than a standalone capital raise. The combined dilution of ~33% of pre-issuance shares outstanding is material and bearish for existing holders.
Key Financial Metrics
Key Facts
- Issued 3,278,039 restricted shares to Mandragola Ltd. upon cashless exercise of the DFSL Warrant (three tranches between Oct 6-12, 2026).
- Issued 195,000 restricted shares to Mayers Ventures LLC for an equity interest in M.E.A. Testing Systems Ltd. and an option to acquire MEA's remaining interest from Motomova Inc.
- Post-issuance shares outstanding: 13,983,094 as of Oct 12, 2026.
- ATM program raised >$6M net at ~$1.11/share average net price (post-1:10 reverse split effective Sep 9, 2026).
- Mayers Ventures LLC filed a Schedule 13D/A on Oct 6, 2026, indicating activist involvement concurrent with this private placement.
Financial Impact
Dilution of ~33% from pre-issuance shares (3,473,039 new shares on ~10,510,055 pre-issuance shares). ATM proceeds >$6M at ~$1.11/share.
Risk Factors
- Significant dilution (~33%) from the share issuances may pressure the stock price.
- Activist investor Mayers Ventures may push for changes, creating uncertainty.
- Continued reliance on the ATM program for capital suggests ongoing cash needs.
- Cashless warrant exercise mechanism with a $0.10 floor could lead to further dilution if the stock price remains low.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-109087 |
| Document: 0001213900-26-109087-index-headers.html | 0001213900-26-109087 |
| Document: 0001213900-26-109087-index.html | 0001213900-26-109087 |
| Document: 0001213900-26-109087.txt | 0001213900-26-109087 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K | $0.2131 | awaiting T+5 | — | $0.2070 (+2.86%) |
Oct 19, 2026 8d ago | 8-K | $0.2335 $0.2073 | ▲ +11.22% | ▲ +11.30% | $0.2070 (+11.35%) |
Oct 13, 2026 14d ago | 8-K | $0.2382 $0.2390 | ▼ −0.34% | ▲ +0.12% | $0.2070 (+13.10%) |
Oct 8, 2026 19d ago | DEFA14A | $0.2850 $0.2230 | ▼ −21.75% | ▼ −19.79% | $0.2070 (−27.37%) |
Oct 8, 2026 19d ago | DEFA14A | $0.2850 $0.2230 | ▼ −21.75% | ▼ −19.79% | $0.2070 (−27.37%) |
Oct 6, 2026 21d ago | SC 13D/A | $0.3110 $0.2600 | ▼ −16.40% | ▼ −16.26% | $0.2070 (−33.44%) |
Oct 5, 2026 22d ago | SC 13G | $0.3110 $0.2600 | ▼ −16.40% | ▼ −16.26% | $0.2070 (−33.44%) |
Oct 5, 2026 22d ago | 8-K | $0.3110 $0.2600 | ▲ +16.40% | ▲ +16.26% | $0.2070 (+33.44%) |
Sep 25, 2026 4w ago | 8-K | $0.5280 $0.3600 | ▼ −31.82% | ▼ −31.60% | $0.2070 (−60.80%) |
Sep 22, 2026 5w ago | 8-K | $0.5500 $0.4008 | ▼ −27.13% | ▼ −26.45% | $0.2070 (−62.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers